Expression of FXR and FGFR4 were decreased in the livers of mice with confirmed NASH when compared to normal mouse liver, and these levels were restored to normal in mice on the same saturated fat diet when treated with proglumide. This evidence concerns the gene FGFR4 and metabolic dysfunction-associated steatohepatitis.